Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5 homo-2-mer 1611-1801
100.0 2×7AG; Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor MCD72 homo-2-mer 1613-1801
100.0 2×EGW; Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhi… homo-2-mer 1613-1801
100.0 2×XL2; Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphate monomer 791-1191
100.0 2×ADP; Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphoribose monomer 791-1191
100.0 1×AR6; Human parp14 (artd8) - macro domain 2 in complex with adenosine-5-diphosphoribose monomer 999-1191
100 1×AR6; Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H10 monomer 1612-1801
100.0 1×7B8; Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK6 monomer 1612-1801
100 1×EE5; Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitor monomer 1612-1801
100.0 1×94Z; PARP14 Macrodomain 2 with inhibitor monomer 1002-1190
97.88 1×9HH; Human PARP14 (ARTD8), catalytic fragment in complex with compound 3 monomer 1613-1801
100.0 1×TZ7; 6×EDO; 1×PEG; 2×GOL; 3×SO4; PARP14 catalytic domain in complex with OUL40 monomer 1613-1801
100.0 1×I1Q; 1×CL; Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK1 monomer 1613-1801
100 1×EBB; Human poly(ADP-ribose) polymerase 14 (PARP14/ARTD8) - catalytic domain in complex with 6(5H)-phenan… monomer 1613-1801
100.0 1×LDR; 2×GOL; crystal structure of PARP14 bound to N-{4-[4-(diphenylmethoxy)piperidin-1-yl]butyl}[1,2,4]triazolo[… monomer 1613-1801
100.0 1×91V; Human PARP14 (ARTD8), catalytic fragment in complex with RBN012759 monomer 1613-1801
100 1×XBA; 1×EDO; Crystal structure of human poly(adp-ribose) polymerase 14, catalytic fragment in complex with an in… monomer 1613-1801
100.0 1×3AB; Human Artd8 (Parp14, Bal2) - catalytic domain in complex with A16(E) monomer 1613-1801
100.0 1×0RZ; Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a pyrimidine… monomer 1614-1801
100 1×FDR; 1×GOL; Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrah… monomer 1614-1801
100.0 1×91J; Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z) monomer 1615-1801
100 1×0RY; 1×NO3; HUman PARP14 (ARTD8)-Macro domain 1 in complex with adenosine-5-diphosphoribose monomer 792-978
100.0 1×APR; Human PARP14 (ARTD8), catalytic fragment in complex with RBN012042 monomer 1615-1801
100 1×XRM; 2×CL; 1×EDO; Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a quinazolin… monomer 1615-1801
100.0 1×QDR; Human PARP14 (ARTD8), catalytic fragment in complex with compound 2 monomer 1616-1801
100 1×FDR; 6×EDO; Human PARP14 (ARTD8), catalytic fragment in complex with RBN011980 monomer 1616-1801
100 1×YFG; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GV4; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×9KS; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GTJ; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GVV; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GUY; PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… monomer 1208-1388
100 2×CL; 1×DMS; 1×GQY; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GUG; PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… monomer 1208-1388
100 2×CL; 1×DMS; 1×AWP; PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… monomer 1208-1388
100 2×CL; 1×DMS; 1×GW1; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GUV; PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… monomer 1208-1388
100 2×CL; 1×DMS; 1×GVY; PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… monomer 1208-1388
100 2×CL; 1×DMS; 1×GV7; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GRY; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GRV; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GWA; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 2×DMS; 1×GT7; HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 monomer 1208-1388
100 1×BR; PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… monomer 1208-1388
100 2×CL; 1×DMS; 1×GT4; PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… monomer 1208-1388
100 2×CL; 1×DMS; 1×GV1; HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 IN COMPLEX WITH ADENOSINE- 5-DIPHOSPHORIBOSE monomer 1208-1388
100 1×AR6; The Crystal Structure of human PARP14 from Biortus. monomer 1208-1387
100 2×GOL; 2×CL;